Global Depression Drugs Market is Expected to Reach $18 Billion, by 2024, Says Variant Market Research
VARIANT MARKET RESEARCH
Yogesh Godse Director 1 help@variantmarketresearch.com
Description - Depression Drugs Market Global Depression Drug Market is estimated to reach $18 billion by 2024; growing at a CAGR of 2.6% from 2016 to 2024. Depression has emerged as one of the most common yet serious mental disorders among people globally. Depression is caused by combination of genetics, biological, environment and psychological factors. According to WHO published in 2016, estimated 350 million people have been affected and depression can lead to suicide. Over 800000 people die due to suicide every year, making it the second leading cause of death in 15-29 year olds. Depression is more common in women than men. Depression drugs works by fixing chemical imbalance, especially, lack of serotonin in the brain. Although effective treatments are available, many individuals with depression do not have access to treatment or do not take treatment, mainly due to lack of knowledge and social stigma. To Know More About This Report, Visit Here: http://bit.ly/2pZLVUZ
Source : Variant Market Research
2
Global Depression Drugs Market Size and Forecast 2015-2024
Source : Variant Market Research
3
Depression Drugs Market Growing geriatric population, increase in the knowledge regarding depression and rising number of generic drug market are expected to drive the market. Moreover, support from government organizations could also support the growth of market. However, lack of resources, lack of trained healthcare providers and social stigma could be a barrier for the growth of market. Research and development and Untapped markets could provide an opportunity for the market in upcoming years.
Source : Variant Market Research
4
Global Depression Drugs Market Share by Region 2024
Source : Variant Market Research
5
Scope of Depression Drugs Market Product Type Segments
Tricyclice Antidepressants Serotonin-Norepinephrine Inhibitors Atypical Antipsychotics Selective Serotonin Reuptake Inhibitors Benzodiazepines, Tetracyclic Antidepressants Monoamine Oxidase Inhibitors Others Application Segments Clinics and Hospitals Research centres
Source : Variant Market Research
6
Scope of Depression Drugs Market Geographical Segments North America ◦ US ◦ Canada ◦ Mexico
Europe ◦ Germany ◦ France ◦ United Kingdom ◦ Spain ◦ Others
Source : Variant Market Research
7
Scope of Depression Drugs Market Geographical Segments Asia-Pacific ◦ China ◦ India ◦ Japan ◦ South Korea ◦ Others
RoW ◦ South America ◦ Middle East ◦ Africa
Source : Variant Market Research
8
Table Of Content Chapter 1. Prefix 1.1. Market Scope 1.2. Report Description 1.3. Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2. Executive Summary
9
Table Of Content Chapter 3. Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Value Chain Analysis 3.4 Market Dynamics 3.4.1 Drivers 3.4.1.1 Impact Analysis 3.4.2. Restraints 3.4.2.1 Impact Analysis 3.4.3 Opportunities 3.5 Porter’s five forces analysis 3.5.1 Factors Impact Analysis …....
Source : Variant Market Research
10
Table Of Content Chapter 7. Company Profiles 7.1 H.Lundbeck, Merck & Co. 7.2 SK Biopharmaceuticals 7.3 Novartis 7.4 AstraZeneca 7.5 Forest Laboratories 7.6 Naurex 7.7 GlaxoSmithKline 7.8 Eli Lilly and Co.
Source : Variant Market Research
11
Contact Us VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com USA Office: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com Or sales@ variantmarketresearch.com India Office (Corporate Headquarter): Office No. FL No.7, Prakash Developers, Survey no 34/A5, Wadgaon Sheri, Nagar Road, Pune – 411014 Tel: +91 20 65337795 Source : Variant Market Research
12
Thank You‌ Follow us
variantmarketresearch
@vmrreports
variant-market-research Variant Market Research
Source : Variant Market Research
13